PerkinElmer (PKI) To Provide NGS Solutions to Macrogen
Tweet Send to a FriendGet Alerts PKI Hot Sheet
Trade PKI Now!
PerkinElmer, Inc. (NYSE: PKI) announced an agreement to provide Next Generation Sequencing (NGS) sample preparation solutions to Macrogen, Inc., a Korean-based global sequencing company.
As part of the agreement, PerkinElmer will provide Macrogen with its Sciclone® NGS Workstation for high throughput automated Next Generation Sequencing sample preparation, the LabChip® XT nucleic acid size selection and collection system, and the LabChip® GX nucleic acid separation system, to automate and increase the company’s sequencing analysis efficiency and throughput.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
As part of the agreement, PerkinElmer will provide Macrogen with its Sciclone® NGS Workstation for high throughput automated Next Generation Sequencing sample preparation, the LabChip® XT nucleic acid size selection and collection system, and the LabChip® GX nucleic acid separation system, to automate and increase the company’s sequencing analysis efficiency and throughput.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- LRAD Corp, (LRAD), Iroquois Master Fund Enter Settlement
- Blackstone Mortgage (BXMT) Prices Larger 22.5M Common Stock Offering
- St. Jude Medical (STJ) Issues Encouraging Update for EnligHTN™ Multi-Electrode Renal Denervation System Following One Year
Create E-mail Alert Related Categories
Corporate News
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
